AllianceBernstein’s AngioDynamics ANGO Stock Holding History

AllianceBernstein’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$479K	Buy	37,267 +67	+0.2%	+$726	﹤0.01%	2659
2025 Q4	$478K	Sell	37,200 -18,900	-34%	-$233K	﹤0.01%	2675
2025 Q3	$627K	Hold	56,100	–	–	﹤0.01%	2561
2025 Q2	$557K	Buy	56,100 +6,700	+14%	+$65.6K	﹤0.01%	2575
2025 Q1	$464K	Sell	49,400 -14,300	-22%	-$150K	﹤0.01%	2585
2024 Q4	$583K	Hold	63,700	–	–	﹤0.01%	2568
2024 Q3	$496K	Hold	63,700	–	–	﹤0.01%	2667
2024 Q2	$385K	Buy	63,700 +8,740	+16%	+$53.9K	﹤0.01%	2811
2024 Q1	$323K	Hold	54,960	–	–	﹤0.01%	2775
2023 Q4	$431K	Hold	54,960	–	–	﹤0.01%	2679
2023 Q3	$402K	Buy	54,960 +12,380	+29%	+$103K	﹤0.01%	2686
2023 Q2	$444K	Buy	42,580 +4,380	+11%	+$42.2K	﹤0.01%	2699
2023 Q1	$395K	Sell	38,200 -5,772	-13%	-$73.9K	﹤0.01%	2666
2022 Q4	$605K	Buy	43,972 +55	+0.1%	+$765	﹤0.01%	2527
2022 Q3	$899K	Buy	43,917 +78	+0.2%	+$1.71K	﹤0.01%	2346
2022 Q2	$848K	Buy	43,839 +63	+0.1%	+$1.29K	﹤0.01%	2433
2022 Q1	$943K	Buy	43,776 +165	+0.4%	+$3.74K	﹤0.01%	2455
2021 Q4	$1.2M	Buy	43,611 +141	+0.3%	+$3.89K	﹤0.01%	2388
2021 Q3	$1.13M	Sell	43,470 -1,770	-4%	-$47.3K	﹤0.01%	2448
2021 Q2	$1.23M	Hold	45,240	–	–	﹤0.01%	2445
2021 Q1	$1.06M	Sell	45,240 -8,510	-16%	-$172K	﹤0.01%	2388
2020 Q4	$824K	Sell	53,750 -7,005	-12%	-$88.9K	﹤0.01%	2379
2020 Q3	$733K	Buy	60,755 +415	+0.7%	+$3.94K	﹤0.01%	2321
2020 Q2	$614K	Buy	60,340 +5,090	+9%	+$52.5K	﹤0.01%	2475
2020 Q1	$576K	Buy	55,250 +50	+0.1%	+$628	﹤0.01%	2277
2019 Q4	$884K	Sell	55,200 -35,770	-39%	-$546K	﹤0.01%	2329
2019 Q3	$1.68M	Sell	90,970 -8,400	-8%	-$164K	﹤0.01%	2022
2019 Q2	$1.96M	Buy	99,370 +15,100	+18%	+$308K	﹤0.01%	1988
2019 Q1	$1.93M	Hold	84,270	–	–	﹤0.01%	1916
2018 Q4	$1.7M	Sell	84,270 -1,090	-1%	-$22.6K	﹤0.01%	1922
2018 Q3	$1.86M	Sell	85,360 -57,180	-40%	-$1.27M	﹤0.01%	1995
2018 Q2	$3.17M	Hold	142,540	–	–	﹤0.01%	1596
2018 Q1	$2.46M	Sell	142,540 -27,370	-16%	-$457K	﹤0.01%	1693
2017 Q4	$2.83M	Buy	169,910 +10,370	+6%	+$177K	﹤0.01%	1607
2017 Q3	$2.73M	Buy	159,540 +110,250	+224%	+$1.85M	﹤0.01%	1629
2017 Q2	$799K	Buy	49,290 +17,200	+54%	+$272K	﹤0.01%	2410
2017 Q1	$557K	Sell	32,090 -181,560	-85%	-$3.04M	﹤0.01%	2495
2016 Q4	$3.6M	Buy	213,650 +44,060	+26%	+$735K	﹤0.01%	1401
2016 Q3	$2.98M	Buy	169,590 +138,500	+445%	+$2.25M	﹤0.01%	1481
2016 Q2	$447K	Buy	31,090 +2,000	+7%	+$25K	﹤0.01%	2556
2016 Q1	$358K	Hold	29,090	–	–	﹤0.01%	2524
2015 Q4	$353K	Sell	29,090 -3,005	-9%	-$37K	﹤0.01%	2569
2015 Q3	$423K	Sell	32,095 -110	-0.3%	-$1.66K	﹤0.01%	2546
2015 Q2	$528K	Hold	32,205	–	–	﹤0.01%	2566
2015 Q1	$573K	Hold	32,205	–	–	﹤0.01%	2428
2014 Q4	$612K	Sell	32,205 -2,400	-7%	-$40.7K	﹤0.01%	2444
2014 Q3	$475K	Sell	34,605 -1,000	-3%	-$14.3K	﹤0.01%	2522
2014 Q2	$581K	Sell	35,605 -2,911	-8%	-$42.1K	﹤0.01%	2475
2014 Q1	$607K	Buy	38,516 +711	+2%	+$11.6K	﹤0.01%	2367
2013 Q4	$650K	Buy	37,805 +3,300	+10%	+$50.8K	﹤0.01%	2338
2013 Q3	$455K	Sell	34,505 -1,101	-3%	-$13K	﹤0.01%	2520
2013 Q2	$402K	Buy	+35,606	New	+$379K	﹤0.01%	2596

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

AllianceBernstein's ANGO Position: Q1 2026 in Review

AllianceBernstein increased its AngioDynamics (ANGO) stake by 0.18% in Q1 2026, buying an estimated $726 and bringing the position to 37,267 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #2659.

AllianceBernstein first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.6M in Q4 2016. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

AllianceBernstein held 37,267 shares of AngioDynamics worth $479K as of Q1 2026.
AllianceBernstein bought 67 AngioDynamics shares in Q1 2026, an estimated $726.
AngioDynamics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2659 holding.
AllianceBernstein first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
AllianceBernstein's AngioDynamics position peaked at $3.6M in Q4 2016.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.